EN DE
STOCK COMPARISON

CU Medical Systems vs InBody Co.Ltd: Fair Value & Quality

Both stocks run through our valuation models. Here is how CU Medical Systems (115480) and InBody Co.Ltd (041830) compare, as of Aug 21, 2026.

As of Aug 21, 2026, Fair Value Calculator sees InBody Co.Ltd as the more attractively valued of the two: CU Medical Systems trades at KRW 2,280 versus a fair value of KRW 1,134 (-50%), while InBody Co.Ltd trades at KRW 59,800 versus KRW 74,549 (+25%).
CU Medical Systems
115480.KQ · KRW · Health Care
-50%
upside to fair value
overvalued
PriceKRW 2,280
Fair ValueKRW 1,134
Quality76/100
InBody Co.Ltd
041830.KQ · KRW · Health Care
+25%
upside to fair value
undervalued
PriceKRW 59,800
Fair ValueKRW 74,549
Quality71/100
Get comparisons like this free by email every month: the most undervalued quality stocks.

Head-to-head numbers

Green value = the better side for that row (for valuation multiples: lower = cheaper).

CU Medical SystemsInBody Co.Ltd
Valuation
0.7×EV/EBITDA
Dividend yield1.8%
Profitability
-6%Net margin24%
24%Operating margin24%
8%Return on assets11%
Growth
57%Revenue growth (YoY)18%
0.9%Avg. growth/yr (3Y)13.5%
11.2%Avg. growth/yr (5Y)16.9%
Balance & size
0.46×Debt / equity0.01×
$15MMarket cap$506M
healthyGrowth qualityhealthy

InBody Co.Ltd leads: 1 to 6 metric wins.

Dash = not meaningfully computable, for example with negative equity.

Quality in detail

The quality score, broken down into the same factor families as on the stock page, 0 to 100 per family.

CU Medical Systemsof which business quality 72 · market factors 28 InBody Co.Ltdof which business quality 68 · market factors 80
ProfitabilityMargins and returns on capital today
28
59
Quality GrowthAre margins and returns improving?
91
45
CashflowEarnings quality: real cash, not paper profit
86
58
Fin. StrengthBalance sheet, leverage, solvency risk
59
90
InvestmentDisciplined investing over empire-building
92
51
Low VolatilityCalm price path (market factor)
57
43
MomentumPrice trend over the last 3–12 months (market factor)
13
97
52W MomentumDistance to the 52-week high (market factor)
20
95
Net IssuanceBuybacks instead of dilution
100
100

What the models say

The median fair value (base case) per model family, each in the currency of its trading venue. Green = above the current price, red = below.

CU Medical Systems

DCF ModelsKRW 9,057
Earnings-BasedKRW 715
MultiplesKRW 4,818
Asset-BasedKRW 2,516
Growth DCFKRW 9,181
Economic ProfitKRW 4,958
Growth EarningsKRW 1,000

7 of 24 models see the stock below the current price.

InBody Co.Ltd

DCF ModelsKRW 65,630
Earnings-BasedKRW 34,626
MultiplesKRW 44,543
Asset-BasedKRW 15,795
Growth DCFKRW 59,979
Economic ProfitKRW 32,522
Growth EarningsKRW 53,096

16 of 24 models see the stock below the current price.

Scenario ranges

From our cautious bear case to the optimistic bull case. The white tick is the current price: left of fair value means room to run.

CU Medical Systems
Bear KRW 851Fair Value KRW 1,134Bull KRW 1,418
KRW 2,280 = current price (white tick)
InBody Co.Ltd
Bear KRW 53,718Fair Value KRW 74,549Bull KRW 91,859
KRW 59,800 = current price (white tick)

Compare two other stocks

Tap a field and type again, ticker or company name.

Free, no sign-up

Ranked within their sector

Where each stock sits within its sector peer group. Band = middle 50% of peers, tick = median, dot = this stock.

CU Medical Systems · Health Care

Quality score76 · Top 25%
Fair value upside-50% · below median

InBody Co.Ltd · Health Care

Quality score71 · Top 25%
Fair value upside+25% · Top 25%

Bottom line

As of Aug 21, 2026, Fair Value Calculator sees InBody Co.Ltd as the more attractively valued of the two: CU Medical Systems trades at KRW 2,280 versus a fair value of KRW 1,134 (-50%), while InBody Co.Ltd trades at KRW 59,800 versus KRW 74,549 (+25%).

CU Medical Systems has the higher quality score (76/100).

See the full analysis →

More comparisons

Popular match-ups from the same sectors, all with fair value and quality score.

Free · Top-25 report

See the undervalued quality stocks every month

Just your email for the monthly Top-25 report of the most undervalued quality stocks, with fair value, quality and price target. Plus 14 days of Pro to try, no card.

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click. Not financial advice.

A model-based valuation snapshot from 21 models. Values change with price and fundamentals; the date shown above applies.